Skip to Content

Nitrofurantoin Patient Tips

Medically reviewed on Nov 16, 2017 by C. Fookes, BPharm.

How it works

  • Nitrofurantoin is an antibacterial agent with a large crystal structure (called a macrocrystal) which restricts absorption through the gastrointestinal tract allowing the nitrofurantoin to concentrate in urine.
  • Once in contact with bacteria, nitrofurantoin is broken down into its active components which inhibit several vital bacterial biochemical processes, such as protein and cell wall synthesis, DNA and RNA synthesis, and aerobic energy metabolism.
  • Nitrofurantoin belongs to the class of medicines known as nitrofuran antibacterials.

Upsides

  • May be used as a treatment for urinary tract infections or at a lower dosage to reduce the recurrence of urinary tract infections.
  • Nitrofurantoin is effective for treating certain gram-negative and gram-positive urinary tract infections, such as those due to Escherichia coli, enterococci, Staphylococcus aureus and susceptible strains of Klebsiella and Enterobacter.
  • Because nitrofurantoin concentrates in urine, side effects are generally less than with other agents typically also used to treat urinary tract infections.
  • Unlike many other antibiotics, resistance to nitrofurantoin has never been a significant problem; experts believe its broad spectrum of action offers a protective effect against resistance development. However, some bacteria are not susceptible to nitrofurantoin and care should still be taken not to encourage the development of resistant bacteria.
  • Generic nitrofurantoin is available.

Downsides

If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include:

  • Nausea or vomiting, changes in facial skin color, dark colored urine, flatulence, headache and weight loss are the most common side effects. Other side effects, such as abdominal pain, constipation, diarrhea, skin reactions, cardiovascular effects are uncommon or relatively rare.
  • Nitrofurantoin has been associated with potentially fatal lung conditions such as interstitial pneumonitis and pulmonary fibrosis. If these develop, nitrofurantoin should be discontinued. The risk is greater in people receiving nitrofurantoin for longer than six months.
  • Not suitable for people with significantly impaired kidney function or in those with a previous history of liver problems associated with nitrofurantoin use.
  • Should not be used in pregnant patients near term (38 to 42 weeks gestation) or when labor is imminent, or in newborns aged less than one month, because of the risk of hemolytic anemia.
  • Because the distribution of nitrofurantoin to other tissues is limited, there is a higher chance that the bacterial infection being treated may persist or recur. Urine samples should be taken both before and after treatment.
  • Should not be taken again by people who have had liver problems or reactions to nitrofurantoin in the past.
  • May cause liver problems, particularly with long-term use. Periodic liver enzyme monitoring may be needed.
  • Long-term use has also been associated with peripheral neuropathy (nerve disease or damage particularly confined to the feet or hands). The risk is greater in people with kidney disease, anemia, diabetes, electrolyte imbalance, vitamin B deficiency or with chronic debilitating diseases. Rarely, optic neuritis (inflammation of the optic nerve) may develop.
  • May also cause other serious side effects such as hemolytic anemia (risk is greater in people with glucose-6-phosphate deficiency) and clostridium difficile infection (symptoms include persistent diarrhea).
  • May interact with quinolone antibiotics and antacids that contain magnesium may reduce the absorption of nitrofurantoin. Probenecid and sulfinpyrazone can inhibit the excretion of nitrofurantoin, which may increase the risk of toxicity and decrease its effectiveness because this lowers the concentration of nitrofurantoin in the urinary tract.

Notes: In general, seniors or children, people with certain medical conditions (such as liver or kidney problems, heart disease, diabetes, seizures) or people who take other medications are more at risk of developing a wider range of side effects. For a complete list of all side effects, click here.

Bottom Line

Nitrofurantoin is an effective antibiotic with a low risk of inducing bacterial resistance that is used specifically to treat urinary tract infections caused by susceptible bacteria. Long-term use has been associated with an increased risk of serious side effects.

Tips

  • Take with food to enhance absorption and decrease the risk of side effects such as nausea.
  • Take exactly as directed by your doctor. Ensure you finish the course as prescribed to decrease the risk of resistant bacteria developing.
  • Do not take antacid or indigestion remedies containing magnesium trisilicate at the same time as taking nitrofurantoin.
  • Nitrofurantoin should only be used to treat infections caused by susceptible bacteria; it does not treat infections caused by viruses. Do not share your nitrofurantoin with anybody else.
  • Talk with your doctor if you start feeling unwell or develop shortness of breath on exertion, a cough that doesn't go away, or a numbness, tingling, or loss of sensation in your fingers or toes.
  • Talk with your doctor if you develop watery or bloody stools with or without other symptoms such as stomach cramps or fever either while taking nitrofurantoin or within two months of discontinuing it.
  • Do not take nitrofurantoin if you are in the last two to four weeks of your pregnancy.
  • If using the oral suspension, shake well before use. Measure the exact dose and then swallow (may be mixed with water, milk or fruit juice before swallowing).
  • Tell any health professional that treats you that you are taking nitrofurantoin as it may interfere with laboratory tests.

Response and Effectiveness

  • The macrocrystalline form of nitrofurantoin allows nitrofurantoin to be absorbed more slowly, reducing any negative effects on the stomach (and decreasing the risk of nausea). An improvement in symptoms may be noticed within a couple of days; however, it is important the course of nitrofurantoin is finished or the drug continues to be taken for at least three days following a clear urine sample.

References

Nitrofurantoin [Package Insert]. BluePoint Laboratories. Revised 03/2017 https://www.drugs.com/pro/nitrofurantoin-capsules.html

  • Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use nitrofurantoin only for the indication prescribed.
  • Disclaimer: Every effort has been made to ensure that this information is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This drug information does not endorse drugs, diagnose patients or recommend therapy. It is an informational resource designed as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of this information. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2018 Drugs.com. Revision Date: 2017-11-15 21:51:00

Hide